X

Trial Profile

Phase II trial of nab-paclitaxel for the treatment of desmoid tumors and multiply relapsed/refractory desmoplastic small round cell tumors and Ewing sarcoma

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 25 Sep 2023

Price : $35 ^*

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Paclitaxel (Primary)
Indications Ewing's sarcoma; Soft tissue sarcoma
Focus Therapeutic Use
Acronyms ABRADES

Most Recent Events

06 Jun 2022 Status changed from active, no longer recruiting to completed.
05 Feb 2021 Planned End Date changed from 30 Sep 2020 to 20 May 2021.
05 Feb 2021 Planned primary completion date changed from 30 Sep 2020 to 20 Feb 2021.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com